James Morey - Universal Health Independent Director
| UHT Stock | USD 41.72 0.10 0.24% |
Director
Mr. James P. Morey is an Independent Director of the company since July, 2018. He has served as the Executive Vice President, Chief Marketing and Brand Officer for Wawa, Inc. since January, 2017. Prior thereto, he held various roles at Wawa, including Chief Operations Officer, responsible for all of Store Operations, Real Estate and Supply Chain, as well as serving as Chief Financial Officer. Prior to joining Wawa, Mr. Morey was Group Vice President of Financial Strategy, Planning, Tax and Treasury for Bloomin Brands, and prior thereto he held various financial and operational roles with McDonalds Corporationrationration. Mr. Morey provides accounting and financial expertise. since 2018.
| Age | 52 |
| Tenure | 7 years |
| Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
| Phone | 610 265 0688 |
| Web | https://www.uhrit.com |
James Morey Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Morey against Universal Health stock is an integral part of due diligence when investing in Universal Health. James Morey insider activity provides valuable insight into whether Universal Health is net buyers or sellers over its current business cycle. Note, Universal Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Universal Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Morey over six months ago Acquisition by James Morey of 400 shares of Universal Health subject to Rule 16b-3 |
Universal Health Management Efficiency
The company has Return on Asset of 0.0404 % which means that on every $100 spent on assets, it made $0.0404 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1011 %, implying that it generated $0.1011 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.15 in 2025, whereas Return On Tangible Assets are likely to drop 0.03 in 2025. At this time, Universal Health's Non Current Liabilities Total is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 378 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 311.8 M in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Alan Gardner | Community Healthcare Trust | 67 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Claire Gulmi | Community Healthcare Trust | 67 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Jay Gellert | Ventas Inc | 66 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Dana Hambly | National Health Investors | N/A | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Melody Barnes | Ventas Inc | 56 | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Henry Cole | Global Medical REIT | 76 | |
| James Shelton | Ventas Inc | 66 | |
| Colleen Schaller | National Health Investors | N/A | |
| Sean Nolan | Ventas Inc | 52 | |
| Robert Reed | Ventas Inc | 68 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Roscoe Moore | Global Medical REIT | 76 | |
| Robert Adams | National Health Investors | 74 | |
| Walter Rakowich | Ventas Inc | 63 | |
| Roxanne Martino | Ventas Inc | 63 | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0404 |
Universal Health Realty Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert McCadden, Lead Independent Trustee | ||
| Cheryl Ramagano, Vice President, Treasurer, Secretary | ||
| Gayle Capozzalo, Independent Trustee | ||
| Judith Romero, Vice Management | ||
| James Morey, Independent Director | ||
| Charles Boyle, Chief Financial Officer, Vice President | ||
| Judith Klein, Vice Management | ||
| Alan Miller, Chairman of the Board of Trustee, President, Chief Executive Officer | ||
| Genevieve Owsiany, VP Controller | ||
| Marc Miller, Trustee | ||
| Karla Peterson, Vice Development | ||
| Timothy Fowler, Vice President - Acquisition and Development | ||
| Michael Domb, Independent Trustee |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0404 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.38 % | ||||
| Current Valuation | 948.95 M | ||||
| Shares Outstanding | 13.85 M | ||||
| Shares Owned By Insiders | 8.07 % | ||||
| Shares Owned By Institutions | 64.41 % | ||||
| Number Of Shares Shorted | 307.88 K | ||||
| Price To Earning | 34.86 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.